Egypt
Factsheet| BIOC | EGX 30 | Rel. Perf. | |
|---|---|---|---|
| Year-to-Date | 5.8% | N/A | N/A |
| 1-Week | -1.1% | N/A | N/A |
| 1-Month | -2.4% | N/A | N/A |
| 1-Year | 22.5% | N/A | N/A |
| 3-Year | N/A | N/A | N/A |
| 5-Year | 208.8% | N/A | N/A |
GlaxoSmithKline |
| Sector: Pharmaceuticals | Ticker: BIOC | ISIN: EGS38171C012 |
|
The Stock Price change percentage is a relevant indicator for computing stock performance. The price change percentage of GlaxoSmithKline over the last month is -2.39%.
The Stock Performance of GlaxoSmithKline is significantly lower than the stock performance of its index.
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The most basic way for computing stock performance is to calculate the price change of the stock over a period of time, shown in percentage. It is also useful to calculate the relative performance of a stock comparing its price change with the change of a benchmark index over the same period. Benchmarking stocks on the basis of their performance could be more complex when calculating total return, which consists in adding to the stock price change any other return from an investment over the period, such as dividends. Furthermore, currency conversion rate must be considered when the investment is made in a different currency, as the exchange rate change over the period affects the actual return of the stock investment.
